PBM Reporting Transparency Act
Official title: A bill to require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on arrangements with pharmacy benefit managers with respect to prescription drug plans MA-PD plans.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
PBM Reporting Transparency Act
This bill requires the Medicare Payment Advisory Commission to report certain information about pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage.
Specifically, the commission must report on trends in agreements between PBMs and prescription drug plans, the impact of any differences in agreements on out-of-pocket spending for enrollees and pharmacy reimbursements, and any appropriate recommendations. The commission must submit an updated report two years after its initial report.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2493: PBM Reporting Transparency Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2493/
"S. 2493: PBM Reporting Transparency Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2493/.
S. 2493, 118th Cong. (2026), https://openamerica.io/bill/118-S-2493/.
[S. 2493: PBM Reporting Transparency Act](https://openamerica.io/bill/118-S-2493/)